Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters











Database
Language
Publication year range
1.
Food Chem Toxicol ; 53: 299-309, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23261680

ABSTRACT

Nucleoside reverse-transcriptase inhibitor (NRTI) drugs are a major component of highly-active antiretroviral therapy (HAART). NRTI combinations have been demonstrated as producing a sustained reduction in plasma viremia with an increased CD4 count, thereby showing clear clinical benefits. Therefore, the secondary effects caused by the combination of two NRTIs, mainly those related to amplification of genotoxic effects, due to increased risk of DNA damage caused by these drugs, should be carefully examined. We employed the standard version of the wing SMART in Drosophila melanogaster to obtain more detailed knowledge about the genotoxic profile of NRTI combinations of AZT+ddI, AZT+3TC and AZT+d4T. Our results showed that all combinations increased the frequencies of induction of mutant spots. The combinations AZT+ddI and AZT+3TC were shown to induce recombination rates ranging from 86.38% to 98.36% while AZT+d4T showed a large discrepancy between recombination and mutation percentages. The combination index demonstrated that 3TC and d4T produced antagonism while ddI showed synergistic effects in combination with AZT.


Subject(s)
Antiviral Agents/adverse effects , DNA Damage/drug effects , Drosophila melanogaster/drug effects , Animals , Anti-HIV Agents/adverse effects , CD4 Lymphocyte Count , Didanosine/adverse effects , Dose-Response Relationship, Drug , Drosophila melanogaster/metabolism , Drug Combinations , Female , Lamivudine/adverse effects , Male , Mitosis , Mutation , Recombinant Proteins , Wings, Animal/drug effects , Zidovudine/adverse effects
SELECTION OF CITATIONS
SEARCH DETAIL